Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, American Healthcare REIT Inc (NYSE: AHR) closed at $42.73 up 2.99% from its previous closing price of $41.49. In other words, the price has increased by $2.99 from its previous closing price. On the day, 1.4 million shares were traded. AHR stock price reached its highest trading level at $42.93 during the session, while it also had its lowest trading level at $41.38.
Ratios:
For a deeper understanding of American Healthcare REIT Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 42.88 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 47.57. For the most recent quarter (mrq), Quick Ratio is recorded 1.52 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, UBS on September 19, 2025, initiated with a Buy rating and assigned the stock a target price of $51.
On July 18, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $41.
On June 30, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $42.Scotiabank initiated its Sector Outperform rating on June 30, 2025, with a $42 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 03 ’25 when Foster Mark E. sold 3,850 shares for $41.89 per share. The transaction valued at 161,271 led to the insider holds 59,100 shares of the business.
Foster Mark E. bought 3,850 shares of AHR for $161,271 on Sep 03 ’25. On Jun 30 ’25, another insider, Oh Stefan K.L., who serves as the Chief Investment Officer of the company, sold 3,860 shares for $36.10 each. As a result, the insider received 139,346 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHR now has a Market Capitalization of 7203218432 and an Enterprise Value of 8828367872. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.39 while its Price-to-Book (P/B) ratio in mrq is 2.90. Its current Enterprise Value per Revenue stands at 4.122 whereas that against EBITDA is 24.421.
Stock Price History:
The Beta on a monthly basis for AHR is 1.03, which has changed by 0.6543062 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, AHR has reached a high of $43.52, while it has fallen to a 52-week low of $24.21. The 50-Day Moving Average of the stock is 2.34%, while the 200-Day Moving Average is calculated to be 23.84%.
Shares Statistics:
For the past three months, AHR has traded an average of 1.39M shares per day and 1204780 over the past ten days. A total of 168.57M shares are outstanding, with a floating share count of 166.93M. Insiders hold about 0.98% of the company’s shares, while institutions hold 89.70% stake in the company. Shares short for AHR as of 1759190400 were 9729278 with a Short Ratio of 7.02, compared to 1756425600 on 3723376. Therefore, it implies a Short% of Shares Outstanding of 9729278 and a Short% of Float of 5.82.
Earnings Estimates
A detailed examination of American Healthcare REIT Inc (AHR) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.17, with high estimates of $0.19 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.37 and $0.31 for the fiscal current year, implying an average EPS of $0.34. EPS for the following year is $0.78, with 3.0 analysts recommending between $0.8 and $0.76.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $552.14M this quarter.It ranges from a high estimate of $565.26M to a low estimate of $547.4M. As of. The current estimate, American Healthcare REIT Inc’s year-ago sales were $523.81MFor the next quarter, 6 analysts are estimating revenue of $563.54M. There is a high estimate of $592.53M for the next quarter, whereas the lowest estimate is $552.6M.
A total of 6 analysts have provided revenue estimates for AHR’s current fiscal year. The highest revenue estimate was $2.24B, while the lowest revenue estimate was $2.18B, resulting in an average revenue estimate of $2.2B. In the same quarter a year ago, actual revenue was $2.07BBased on 6 analysts’ estimates, the company’s revenue will be $2.35B in the next fiscal year. The high estimate is $2.52B and the low estimate is $2.3B.
